Coronary heart disease in women: Evolution of our knowledge

Psychosocial Stress and Cardiovascular Disease in Women: Concepts, Findings, Future Perspectives

Volumn , Issue , 2015, Pages 13-25

  Wenger, Nanette Kass ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary heart disease; Coronary risk factors in women; Microvascular angina; Revascularization in women; Women

Indexed keywords

EID: 84943592206     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-09241-6_3     Document Type: Chapter

References (73)

1. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Retrieved from http://circ.ahajournals.org/content/early/2013/11/11/01.cir.0000437738.63853.7a.citation
2. Albert, C. M., Cook, N. R., Gaziano, J. M., Zaharris, E., MacFadyen, J., Danielson, E., Manson, J. E. (2008). Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: A randomized trial. JAMA, 299(17), 2027-2036.
3. Anderson, J. S., & Pepine, C. J. (2007). Gender differences in the treatment for acute myocardial infarction: Bias or biology? Circulation, 115(1), 823-826.
4. Anderson, H. V., Stokes, M. J., Leon, M., Abu-Halawa, S. A., Stuart, Y., & Kirkeeide, R. L. (2000). Coronary artery flow velocity is related to lumen area and regional left ventricular mass. Circulation, 102(1), 48-54.
5. Baillargeon, J. P., McClish, D. K., Essah, P. A., & Nestler, J. E. (2005). Association between the current use of low-dose oral conceptives and cardiovascular arterial disease: A meta-analysis. Journal of Clinical Endocrinology and Metabolism, 90(7), 3863-3870.
6. Bangalore, S., Fonarow, G. C., Peterson, E. D., Hellkamp, A. S., Hernandez, A. F., Laskey, W., for the Get with the Guidelines Steering Committee and Investigators. (2012). Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction. The American Journal of Medicine, 125(10), 1000-1009.
7. Berger, J. S., Elliott, L., Gallup, D., Roe, M., Granger, C. B., Armstrong, P. W., Douglas, P. S. (2009). Sex differences in mortality following acute syndromes. JAMA, 302(8), 874-882.
8. Blomkalns, A. L., Chen, A.Y., & Hochman, J. S. (2005). Gender disparities in diagnosis and treatment of non-ST segment elevation acute coronary syndromes. Large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. Journal of the American College of Cardiology, 45(6), 832-837.
9. Bonamy, A.-K. E., & Parikh, N. I. (2013). Predicting women’s future cardiovascular health from pregnancy complications. Current Cardiovascular Risk Reports, 7(3), 173-182.
10. Bugiardiini, R., Yan, A. T., Yan, R. T., Fitchett, D., Langer, A., Manfrini, O., Acute Coronary Syndrome Registry I and II Investigators. (2011). Factors influencing underutilization of evidence-based therapies in women. The European Heart Journal, 32(11), 1337-1344.
11. Canto, A. J., Kiefe, C. I., Goldberg, R. J., Rogers, W. J., Peterson, E. D., Wenger, N. K., Canto, J. G. (2012). Differences in symptom presentation and hospital mortality according to type of acute myocardial infarction. American Heart Journal, 163(4), 572-579.
12. Canto, J. G., Rogers, W. J., Goldbergm R. J., Peterson, E. D., Wenger, N. K., Vaccarino, V., NRMI Investigators. (2012). Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA, 307(8), 823-826.
13. Clarke, R., Halsey, J., Lewington, S., Lonn, E., Armitage, J., Manson, J. E., B-Vitamin Treatment Trialists’ Collaboration. (2010). Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37,485 individuals. Archives of Internal Medicine, 770(18), 1622-1631.
14. Committee on Women’s Health Board on Population Health and Public Health Practices. (2013). Women’s health research, progress, pitfalls, and promise. Washington, DC: Institute of Medicine, National Academies Press
15. Cook, N. R., Albert, C. M., Gaziano, J. M., Zaharris, E., MacFadyen, J., Danielson, E., Manson, J. E. (2007). A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: Results from the Women’s Antioxidant Cardiovascular Study. Archives of Internal Medicine, 167(15), 1610-1618.
16. D’Antonio, B., Dupuis, G., Fortin, C., Arsenault, A., & Burelle, D. (2006). Angina symptoms in men and women with stable coronary artery disease and evidence of exercise-induced myocardial perfusion defects. American Heart Journal, 151(4), 813-819.
17. Daly, C., Clemens, F., Lopez Sendon, J. L., Tavazzi, L., Boersma, E., Danchin, N., Euro Heart Survey Investigators. (2006). Gender differences in the management and clinical outcome of stable angina. Circulation, 113(4), 490-498.
18. Duvemoy, C. S. (2012). Evolving strategies for the treatment of microvascular angina in women. Expert Review of Cardiovascular Therapy, 10(11), 1413-1419.
19. Eneberdine, N., & Weneer, N. K. (2012). Management of hypertension on women. Hypertension Research, 35(3), 251-260.
20. Ford, E. S., Ajani, U., & Croft, J. B. (2007). Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. The New England Journal of Medicine, 356(23), 2388-2398.
21. Gholizadeh, L., & Davidson, P. (2008). More similarities than differences: An international comparison of C VD mortality and risk factors in women. Health Care for Women International, 29(1), 3-22.
22. Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2013). Heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation, 127(3), e28-e292.
23. Gregg, E. W., Gu, Q., Cheng, Y. J., Venkat Narayan, K. M., & Cowie, C. C. (2007). Mortality trends in men and women with diabetes, 1971 to 2000. Annals of Internal Medicine, 147(3), 149-155.
24. Gulati, M., Cooper-DeHoff, R. M., McClure, C., Johnson, B. D., Shaw, L. J., Handberg, E. M., Merz, C. N. (2009). Adverse cardiovascular outcomes in women with non-obstructive coronary artery disease: A report from the Women’s Ischemia Syndrome Evaluation Study and the St. James Women Take Heart Project. Archives of Internal Medicine, 169(9), 843-850.
25. Hemingway, H., Langenberg, C., Damant, J., Frost, C., Pyorala, K., & Barrett-Connor, E. (2008). Prevalence of angina in women versus men: A systematic review and meta-analysis of international variations across 31 countries. Circulation, 117(12), 1526-1536.
26. Hochman, J. S., McCabe, C., Stone, P. H., Becker, R. C., Cannon, C. P., DeFeo-Fraulini, T., Braunwald, E. (1997). Outcome and profile of women and men presenting with acute coronary syndrome: A report from TIMI IIIB. Journal of the American College of Cardiology, 30(1), 141-148.
27. Hochman, J. S., Tamis, J., Thompson, T. D., Weaver, W. D., White, H. D., Van de Werf, F., Califf, R. M. (1999). Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global use of strategies to open occluded coronary arteries in acute coronary syndromes lib investigators. The New England Journal of Medicine, 341(3), 226-232.
28. Hsai, J., Heiss, G., Ren, H., Allison, M., Dolan, N. C., Greenland, P., Women’s Health Initiative Investigators (2007). Calcium/vitamin D supplementation and cardiovascular events. Circulation, 115(1), 846-854.
29. Huxley, R. R., & Woodward, M. (2011). Cigarette smoking as a risk factor for coronary heart disease in women compared with men: A systematic review and meta-analysis of prospective cohort studies. Lancet, 378(9199), 1297-1305.
30. Jneid, H., Fonarow, G. C., Cannon, C. P., Hernandez, A. F., Palacios, I. F., Maree, A. O., Get With the Guidelines Steering Committee and Investigators. (2008). Sex differences in medical care and early death after acute myocardial infarction. Circulation, 118(25), 2803-2810.
31. Kanaya, A. M., Grady, D., & Barrett-Connor, E. (2002). Explaining the sex differences in coronary heart disease mortality among patients with type 2 diabetes mellitus: A meta-analysis. Archives of Internal Medicine, 762(15), 1737-1745.
32. Kaul, S., Morrissey, R. P., & Diamond, G. A. (2010). By Jove! What is a clinician to make of JUPITER? Archives of Internal Medicine, 170(12), 1073-1077.
33. Khan, N. A., Daskalopoulou, S. S., Karp, I., Eisenberg, M. J., Pelletier, R., Tsadok, M. A., for the GENESIS PRAXY Team. (2013). Sex differences in acute coronary syndrome presentation in young patients. JAMA Internal Medicine, 173(20), 1863-1871.
34. Khuddus, M. A., Pepine, C. J., Handberg, E. M., Bairey Merz, C. N., Sopko, G., Bavry, A. A., Anderson, R. D. (2010). An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease. A substudy from the National Heart, Lung and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE). Journal of Interventional Cardiology, 23(6), 511-519.
35. Kovacic, J. C., Mehran, R., Karajgkar, R., Baber, U., Suleman, J., Kim, M. C., Kini, A. (2011). Female gender and mortality after percutaneous coronary intervention. Catheterization and Cardiovascular Interventions, 80(4), 514-521.
36. Lichtman, J. H., Shaw, L. J., Arai, A., Budoff, M. J., Flamm, S. D., Hundley, W. G., Wenger, N. K. (2010). Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation, 777(5), 682-696.
37. Lonn, E., Yusuf, S., Arnold, M. J., Sheridan, P., Pogue, J., Micks, M., Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. (2006). Homocysteine lowering with folic acid and B vitamins in vascular disease. The New England Journal of Medicine, 354(15), 1567-1577.
38. Manson, J. E., Chlebowski, R. G., Stefanik, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Wallace R. B. (2013). Menopausal hormone therapy and health outcomes during intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA, 310(13), 1353-1368.
39. Mieres, J. H., Shaw, L. J., Arai, A., Budoff, M. J., Flamm, S. D., Hundley, W. G., Wenger, N. K. (2005). Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus Statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation, 111(5), 682-696.
40. Milner, K. A., Funk, M., Richards, S., Wilmes, R. M., Vaccarino, V., & Krumholz, H. M. (1999). Gender differences in symptom presentation associated with coronary heart disease. The American Journal of Cardiology, 84(4), 396-399.
41. Mosca, L., Banka, C., Benjamin, E. J., Berra, K., Bushnell, C., Dolor, R. J., Expert Panel Writing Group. (2007). Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Journal of the American College of Cardiology, 49(11), 1230-1250.
42. Mosca, L., Benjamin, E. J., Berra, K., Bezanson, J. L., Dolor, R. J., Lloyd-Jones, D. M., Wenger, N. K. (2011). Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: A guideline from the American Heart Association. Circulation, 123(11), 1243-1262.
43. Mosca, L., Mochari-Greenberger, H., Dolor, R. J., Newby, L. K., & Robb, K. J. (2010). Twelveyear follow-up of American women’s awareness of cardiovascular disease and risk barriers in heart health. Circulation: Cardiovascular Quality and Outcomes, 3(2), 120-127.
44. Moyer, V. A., on behalf of the U.S. Preventive Services Task Force. (2013). Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 155(1), 47-54.
45. O’Donoghue, M., Boden, W., Braunwalt, E., Cannon, C. P., Clayton, T. C., de Winter, R. J., (2008). Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction. A meta-analysis. JAMA, 200(1), 71-80.
46. Pain, T. E., Jones, D. A., Rathod, K. S., Gallagher, S. M., Knight, C. J., Mathur, A., Wragg, A. (2013). Influence of female sex on long-term mortality after acute coronary syndromes treated by percutaneous coronary intervention: A cohort study of 7304 patients. Coronary Artery Disease, 24(3), 183-190.
47. Pasternak, R. C., & Abrams, J. (2003). 34th Bethesda conference: Task force #1-Identification of coronary heart disease: Is there a detection gap? Journal of the American College of Cardiology, 4(11), 1863-1874.
48. Pepine, C. J., Anderson, R. D., Sharaf, B. L., Reis, S. E., Smith, K. M., Handberg, E. M., Bairey Merz, C. N. (2010). Coronary micro vascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia: Results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study. Journal of the American College of Cardiology, 55(25), 2825-2832.
49. Prescott, E., Hippe, M., Schonohr, P., Hein, H. O., & Vestbo, J. (1998). Smoking and risk of myocardial infarction in women and men: Longitudinal population study. British Medical Journal, 316(1131), 1043-1047.
50. Puskas, J. (2007). Off-pump techniques benefit men and women and narrow the disparity in mortality after coronary bypass grafting. The Annals of Thoracic Surgery, 84(4), 1147-1156.
51. Rashidi, A., Rahman, M., Wright, J. T., Jr., Alexander, R., & O-Rourke, R. A. (2008). Diagnosis and treatment of hypertension. In V. Fuster et al. (Eds.), Hurst’s the heart (12th ed., pp. 1610-1629). New York, NY: McGraw-Hill.
52. Ridker, P. M., Cook, N. R., Lee, I.-M., Gordon, D., Gaziano, J. M., Manson, J. E. (2005). A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. The New England Journal of Medicine, 352(13), 1293-1304.
53. Ridker, P., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Jr., Kastelein, J. J. JUPITER Study Group. (2008). Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. The New England Journal of Medicine, 359(21), 2195-2207.
54. Risk Assessment Working Group. Pooled Cohort Risk Assessment Equations. Retrieved from http://my.americanheart.org/cvriskcalculator and http://www.cardiosource.org/science-andquality/practice-guidelines-and-quality-standards/2013-prevention-guideline-tools.aspxfor risk equations.
55. Robinson, J. G., Wallace, R., Limacher, M., Ren, H., Cochrane, B., Wassertheil-Smoller, S., Ko, M. G. (2008). Cardiovascular risk in women with non-specific chest pain (from the Women’s Health Initiative Hormone Trials). The American Journal of Cardiology, 102(6), 693-699.
56. Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., WylieRosett, J. (2011). Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation, 123(4), el8-e209.
57. Rosengren, A., Wallentin, L. K., Gitt, A. K., Behar, S., Battler, A., & Hasdai, D. (2004). Sex, age, and clinical presentation of acute coronary syndromes. The European Heart Journal, 25(8), 663-670.
58. Shah, A. S. V., Griffiths, M., Lee, K. K., McAlister, D. A., Hunter, A. L., Cruikshank, A. (2013). High-sensitivity cardiac troponin and the under diagnosis of myocardial infarction in women. Presented at the European Society of Cardiology Congress, Amsterdam, September 4, 2013.
59. Shaw, L. J., Bugiardini, R., & Bairey Merz, C. N. (2009). Women and ischemia heart disease: Evolving knowledge. Journal of the American College of Cardiology, 54(17), 1561-1575.
60. Shaw, L. J., Mieres, J. H., Hendel, R. H., Boden, W. E., Gulati, M., Veledar, E. WOMEN Trial Investigators. (2011). Comparative effectiveness of exercise electrocardiography with or without myocardial perfusion single photon emission computed tomography in women with suspected coronary artery disease. Circulation, 124(11), 1239-1249.
61. Spencer, E. A., Pirie, K., Stevens, R. J., Beral, V., Brown, A., Liu, B. Million Women Study Collaborators. (2010). Diabetes and modifiable risk factors for cardiovascular disease. The prospective Million Women Study. European Journal of Epidemiology, 23(12), 793-799.
62. Stefanini, G. G., Baber, U., Windecker, S., Morice, M. C., Sartori, S., Leon, M. B. Mehran, R. (2013). Safety and efficacy of drug-eluting stents in women: A patient-level pooled analysis of randomised trials. Lancet. Published online September 2, 2013. doi: http://dx.d0i.0rg/l0.1016/S0140-6736(13)61782-l
63. U.S. Preventive Services Task Force. (2009). Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 150(6), 396-404.
64. Vaccarino, V., Abramson, J. L., Veledar, E., & Weintraub, W. S. (2002). Sex differences in hospital mortality after coronary artery bypass surgery: Evidence for a higher mortality in younger women. Circulation, 105(10), 1176-1181.
65. Vaccarino, V., Parsons, L., Peterson, E. D., Rogers, W. J., Kiefe, C. I., & Canto, J. (2009). Sex differences in mortality after acute myocardial infarction: Changes from 1994 to 2006. Archives of Internal Medicine, 169(19), 1767-1774.
66. Von Mering, G. O., Arrant, C. B., Wessel, T. R., McGorray, S. P., Bairey Merz, C. N., Sharaf, B. L. National Heart, Lung, and Blood Institute. (2004). Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: Results from the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation, 109(6), 711-725.
67. Wassertheil-Smoller, S., Hendrix, S. L., Limacher, M., Heiss, G., Kooperberg, C., Baird, A., WHI Investigators. (2003). Effect of estrogen plus progestin on stroke in postmenopausal women: The Women’s Health Initiative: A randomized trial. JAMA, 289(20), 2673-2684.
68. Weintraub, W. S., Wenger, N. K., Jones, E. L., Craver, J. M., & Guyton, R. A. (1993). Changing clinical characteristics of coronary surgery patients. Differences between men and women. Circulation, 88(5), 1179-1186.
69. Wenger, N. K. (2012). Women and coronary heart disease: A century after Herrick. Understudied, underdiagnosed, and undertreated. Circulation, 126(5), 604-611.
70. Wenger, N. K. (2014a). Hormone therapy not recommended for chronic disease prevention in menopausal women. Evidence-Based Medicine, 18(3), 109-110.
71. Wenger, N. K. (2014b). Recognizing pregnancy-associated cardiovascular risk factors. The American Journal of Cardiology, 113(2), 406-409.
72. Wenger, N. K., Shaw, L. J., & Vaccarino, V. (2008). Coronary heart disease in women. Update 2008. Clinical Pharmacology and Therapeutics, 83(1), 37-51.
73. Writing Group for the Women’s Health Initiative Investigators. (2002). Risks and benefits of estrogen plus progestin in healthy post-menopausal women: Principal results of the Women’s Health Initiative randomized controlled trial. JAMA, 288(3), 321-333.